$1.47
arrow_drop_up4.14%Key Stats | |
---|---|
Open | $1.45 |
Prev. Close | $1.45 |
EPS | -0.21 |
Dividend | Non-Dividend |
Next Earnings Date | - |
Dividend Yield % | - |
Market Cap | $182.34M |
PE Ratio | - |
LOW | HIGH | |
---|---|---|
Day Range | 1.40 | 1.45 |
52 Week Range | 0.62 | 2.31 |
Ratios | |
---|---|
Revenue | - |
EBITDA Margin % | - |
EPS | -0.21 |
Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.
Period: Next 12 Months
•Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
Atossa Therapeutics Announces Updated Protocol for Clinical Trial Evaluating (Z)-Endoxifen in Combination with Abemaciclib (VERZENIO®) in Women with ER+/HER2- Breast Cancer
Are Medical Stocks Lagging Alvotech (ALVO) This Year?
Atossa Set to Join Russell 3000® Index Effective June 28, 2024
Is Atossa Genetics (ATOS) Stock Outpacing Its Medical Peers This Year?
Atossa to Present at the Sidoti Small-Cap Investor Conference
Atossa Therapeutics Announces Support of Clinical Study Testing New, Artificial Intelligence, Breast Cancer Risk Assessment Model